On Tuesday, Mimedx Group Inc (NASDAQ: MDXG) opened higher 2.36% from the last session, before settling in for the closing price of $6.36. Price fluctuations for MDXG have ranged from $3.49 to $9.27 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has dropped its sales by -1.19% annually for the last half of the decade. Company’s average yearly earnings per share was noted -13.51% at the time writing. With a float of $112.98 million, this company’s outstanding shares have now reached $146.23 million.
In an organization with 895 employees, it is important to assess its efficiency.
Mimedx Group Inc (MDXG) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Mimedx Group Inc is 23.12%, while institutional ownership is 41.73%. The most recent insider transaction that took place on Mar 13 ’24, was worth 162,029. In this transaction General Counsel and CAO of this company sold 20,381 shares at a rate of $7.95, taking the stock ownership to the 479,959 shares. Before that another transaction happened on Feb 20 ’24, when Company’s Chief Operating Officer sold 15,271 for $8.01, making the entire transaction worth $122,351. This insider now owns 401,050 shares in total.
Mimedx Group Inc (MDXG) Performance Highlights and Predictions
If we go through the results of last quarter, which was made public on 12/31/2023, the company posted -0.06 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.09) by 0.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.08 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -13.51% per share during the next fiscal year.
Mimedx Group Inc (NASDAQ: MDXG) Trading Performance Indicators
Check out the current performance indicators for Mimedx Group Inc (MDXG). In the past quarter, the stock posted a quick ratio of 3.11. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.98. Likewise, its price to free cash flow for the trailing twelve months is 38.59.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.34, a number that is poised to hit 0.04 in the next quarter and is forecasted to reach 0.43 in one year’s time.
Technical Analysis of Mimedx Group Inc (MDXG)
Let’s dig in a bit further. During the last 5-days, its volume was 0.7 million. That was inferior than the volume of 0.76 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 42.63%. Additionally, its Average True Range was 0.25.
During the past 100 days, Mimedx Group Inc’s (MDXG) raw stochastic average was set at 12.93%, which indicates a significant decrease from 38.32% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 38.61% in the past 14 days, which was lower than the 41.43% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.58, while its 200-day Moving Average is $7.54. However, in the short run, Mimedx Group Inc’s stock first resistance to watch stands at $6.63. Second resistance stands at $6.74. The third major resistance level sits at $6.91. If the price goes on to break the first support level at $6.34, it is likely to go to the next support level at $6.17. Assuming the price breaks the second support level, the third support level stands at $6.06.
Mimedx Group Inc (NASDAQ: MDXG) Key Stats
There are currently 146,958K shares outstanding in the company with a market cap of 956.71 million. Presently, the company’s annual sales total 321,480 K according to its annual income of 58,230 K. Last quarter, the company’s sales amounted to 86,830 K and its income totaled 53,480 K.
